Harnessing DLL3 inhibition: From old promises to new therapeutic horizons.

Front Med (Lausanne) · 2022 · PMC9751403 · PMID 36530878

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

However, with regard to PFS, a favorable trend was observed for DLL3-high tumors.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.